Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
16.80
-0.49 (-2.83%)
Nov 17, 2026, 3:00 PM CST
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 6.78 billion as of November 16, 2026. It is the 9,680th most valuable company in the world and the 2,116th biggest in China. Its market cap has decreased by 29.06% in one year.
Market Cap
6.78B
Enterprise Value
7.15B
Revenue
1.67B
Global Rank
Country Rank
#2,116 China
PE Ratio
21.78
ChartMarket Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 6.78B, an increase of 40.26%. That is a compound annual growth rate of 5.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 6.78B | -33.39% |
| Dec 31, 2025 | 10.18B | 18.61% |
| Dec 31, 2024 | 8.58B | -18.20% |
| Dec 29, 2023 | 10.49B | 4.58% |
| Dec 30, 2022 | 10.03B | 13.58% |
| Dec 31, 2021 | 8.83B | 38.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vcanbio Cell & Gene Engineering Corp., | 7.65B |
| InventisBio | 7.64B |
| Jiangxi Fushine Pharmaceutical | 7.33B |
| BeBetter Med | 7.30B |
| Daan Gene | 7.28B |
| Novogene | 7.24B |
| Chengdu Easton Biopharmaceuticals | 7.08B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 6.96B |